Validation and comparison of the molecular international prognostic scoring system (IPSS-M) and the revised international prognostic scoring system (IPSS-R) in myelodysplastic neoplasms (MDS): a retrospective study
IPSS-M demonstrates enhanced prognostic capability over IPSS-R for MDS patients, necessitating further validation in larger cohorts.
Authors
- Yingying Shen (ORCID: https://orcid.org/0000-0001-8492-0848)
- Liqiang Wu (ORCID: https://orcid.org/0000-0001-6754-8175)
- Baodong Ye (ORCID: https://orcid.org/0000-0001-5912-2633)
- Qinghong Yu (ORCID: https://orcid.org/0000-0002-7326-7609)
- Ming Zhou (ORCID: https://orcid.org/0000-0003-4938-5397)
- Mengmeng Hu (ORCID: https://orcid.org/0009-0002-3977-8031)
- Bo Wang (ORCID: https://orcid.org/0000-0002-3307-6058)
- Shengyun Lin (ORCID: https://orcid.org/0000-0003-4262-3903)
- Zhiyin Zheng
Institutions
- Zhejiang Chinese Medical University (CN)
- Shaoxing University (CN)
- Shaoxing People's Hospital (CN)
Publication Details
- Journal
- Hematology
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1080/16078454.2025.2479257
- Citations
- 2
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 3.54